ATE526954T1 - Atomoxetin zur behandlung von allergischer rhinitis und asthma - Google Patents

Atomoxetin zur behandlung von allergischer rhinitis und asthma

Info

Publication number
ATE526954T1
ATE526954T1 AT04779258T AT04779258T ATE526954T1 AT E526954 T1 ATE526954 T1 AT E526954T1 AT 04779258 T AT04779258 T AT 04779258T AT 04779258 T AT04779258 T AT 04779258T AT E526954 T1 ATE526954 T1 AT E526954T1
Authority
AT
Austria
Prior art keywords
atomoxetine
treatment
asthma
allergic rhinitis
mammal
Prior art date
Application number
AT04779258T
Other languages
English (en)
Inventor
Leslie Joe Dunaway
Original Assignee
Leslie Joe Dunaway
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leslie Joe Dunaway filed Critical Leslie Joe Dunaway
Application granted granted Critical
Publication of ATE526954T1 publication Critical patent/ATE526954T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04779258T 2003-07-28 2004-07-27 Atomoxetin zur behandlung von allergischer rhinitis und asthma ATE526954T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49064403P 2003-07-28 2003-07-28
PCT/US2004/024125 WO2005011583A2 (en) 2003-07-28 2004-07-27 Treatment of allergic rhinitis and asthma

Publications (1)

Publication Number Publication Date
ATE526954T1 true ATE526954T1 (de) 2011-10-15

Family

ID=34115419

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04779258T ATE526954T1 (de) 2003-07-28 2004-07-27 Atomoxetin zur behandlung von allergischer rhinitis und asthma

Country Status (4)

Country Link
US (1) US20060100290A1 (de)
EP (1) EP1708717B1 (de)
AT (1) ATE526954T1 (de)
WO (1) WO2005011583A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210353563A1 (en) * 2020-03-26 2021-11-18 Charles McDaniel Composition and method for treatment of respiratory disorders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194009A (en) * 1974-01-10 1980-03-18 Eli Lilly And Company Aryloxyphenylpropylamines for obtaining a psychotropic effect
US4018895A (en) * 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
US4777291A (en) * 1985-02-27 1988-10-11 Eli Lilly And Company Racemization process
US5658590A (en) * 1995-01-11 1997-08-19 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
UA56257C2 (uk) * 1997-09-23 2003-05-15 Елі Ліллі Енд Компані Спосіб лікування неадекватної визивної поведінки
US6008412A (en) * 1997-10-14 1999-12-28 Eli Lilly And Company Process to make chiral compounds
US6541668B1 (en) * 1999-04-09 2003-04-01 Eli Lilly And Company Methods for preparing 3-arloxy-3-arylpropylamines and intermediates thereof
EA200200948A1 (ru) * 2000-03-07 2003-02-27 Эли Лилли Энд Компани Лечение псориаза
ES2295435T3 (es) * 2001-12-11 2008-04-16 Eli Lilly And Company Uso de inhibidores de la recaptacion de norepinefrina para el tratamiento del fallo cognitivo.
US6705067B2 (en) * 2002-07-16 2004-03-16 Case Corporation Feed conveyor/rock trap and header drive for an agricultural combine
US20040235925A1 (en) * 2002-12-17 2004-11-25 Pharmacia Corporation Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof
KR20050094843A (ko) * 2003-01-13 2005-09-28 다이노젠 파마세우티컬스, 인코포레이티드 욕지기, 구토, 구역질 또는 이들의 조합을 치료하는 방법

Also Published As

Publication number Publication date
WO2005011583A2 (en) 2005-02-10
EP1708717A2 (de) 2006-10-11
WO2005011583A3 (en) 2005-03-10
EP1708717A4 (de) 2010-03-17
US20060100290A1 (en) 2006-05-11
EP1708717B1 (de) 2011-10-05
WO2005011583A8 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
ATE325612T1 (de) Verwendung von hydroxyethylrutosiden zur behandlung von erkältungssymptomen, symptomen der allergischen rhinitis und atemwegsinfektionen
ATE519488T1 (de) Aminopyrazin-analoga zur behandlung von glaukomen und anderen durch rho-kinase verursachten krankheiten
ATE544748T1 (de) Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen
DE602004010407D1 (de) Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
BRPI0607402A2 (pt) uso de inibidores de pde7 para o tratamento de dor neuropática
ATE427759T1 (de) Behandlung von fettsucht und verbundenen erkrankungen
MXPA06014510A (es) Composiciones y metodos para tratar trastornos inflamatorios.
ATE413385T1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
ATE315390T1 (de) Zyklische polyamine zur behandlung der thrombozytopenie
DE50109156D1 (de) Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd
DE602006009786D1 (de) Anwendung von molekülen und verfahren zur behandlung von mit mcp-1/ccr2 assoziierten krankheiten
DE602004023721D1 (de) Zusammensetzungen und methoden für die behandlung von herzerkrankungen
ATE541565T1 (de) Topische verwendung von muskarinischen und opioiden mitteln zur behandlung von tinnitus
ATE448779T1 (de) Methode zur behandlung trockener augen und uveitis
ATE406171T1 (de) Aplidine zur behandlung von multiplem myelom
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
ATE526954T1 (de) Atomoxetin zur behandlung von allergischer rhinitis und asthma
ATE360425T1 (de) Verwendung von quetiapin für die behandlung von kokain-abhängigkeit
ATE392212T1 (de) Verwendung eines proteasom-inhibitors zur behandlung fibrotischer erkrankungen
ATE536874T1 (de) Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen
DE60109594D1 (de) R-eliprodil zur behandlung von glaucoma
TNSN06147A1 (en) Use of cathepsin k inhibitors for treating of severe bone loss diseases
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы
NO20053247D0 (no) Anvendelse av levocetirizin ved behandling av vedvarende allergisk rhinitt.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1708717

Country of ref document: EP